|Day Low/High||56.42 / 56.88|
|52 Wk Low/High||49.96 / 70.05|
Bristol-Myers Squibb Company (NYSE: BMY) today announced Opdivo (nivolumab) 3 mg/kg plus low-dose Yervoy (ipilimumab) 1 mg/kg (injections for intravenous use) received approval from the U.
OPDIVO® (nivolumab) + YERVOY® (ipilimumab) combination is the first and only treatment to show significantly superior overall survival versus current standard of care in intermediate- and poor-risk advanced or metastatic renal cell carcinoma 1 MONTREAL,...
Bristol-Myers Squibb Company (NYSE:BMY) today announced that the European Commission (EC) has expanded the indication for Sprycel (dasatinib) to include the treatment of children and adolescents aged 1 year to 18 years with Philadelphia...
Bristol-Myers Squibb Company (NYSE:BMY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended expanded approval of the current indications for Opdivo (nivolumab) to include the...
Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S.
Jim Cramer weighs in on Under Armour, Cognex, Novocure, FireEye, Weight Watchers, Bristol-Meyers Squibb and Chegg.
Jim Cramer explains why the fulcrum for the financial markets is growth -- not tariffs, or the Fed, or interest rates.
Dak Prescott, quarterback of the Dallas Cowboys, Eric Stonestreet, star of television's hit comedy "Modern Family," and Tia Mowry of YouTube's "Tia Mowry's Quick Fix" are teaming up with Bristol-Myers Squibb to launch the Ready.
Harley-Davidson is among these names showing technical reversal patterns over the past week.
The latest announcement from the U.S. Trade Representative's office is chilling reading for free trade supporters.
Bristol-Myers Squibb Company (NYSE: BMY) announced today that the China National Drug Administration (CNDA) has approved Opdivo (nivolumab injection) for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior...
The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a quarterly dividend of forty cents ($0.
Bristol-Myers Squibb Company (NYSE: BMY) today confirmed that 31 abstracts demonstrating The Company's immunoscience-research focus as well as how ORENCIA ® (abatacept) therapy may impact diverse patient subgroups will be presented at the Annual European...
Bristol-Myers Squibb Company (NYSE: BMY) will take part in Goldman Sachs 39 th Annual Global Healthcare Conference on Wednesday, June 13, 2018, in Rancho Palos Verdes, CA.
Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the second quarter of 2018 on Thursday, July 26, 2018.
Every year there are 'winners' and 'losers' from the biggest confab around oncology of the year.
Nektar Therapeutics shares got destroyed on Monday. Here is why.
Bristol-Myers Squibb Company (NYSE:BMY) today announced updated results from the Phase 3 CheckMate -238 trial evaluating Opdivo (nivolumab) versus Yervoy (ipilimumab) in patients with stage IIIB/C or stage IV melanoma who are at high risk of recurrence...
Data from the Phase 1 dose-escalation and early data from the Phase 2 dose expansion phase of the ongoing PIVOT study highlighted as an oral presentation
Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S.
Bristol-Myers Squibb Company (NYSE:BMY) today announced patient-reported outcomes data from the Phase 3 CheckMate -214 trial in intermediate- and poor-risk patients with advanced renal cell carcinoma (RCC) treated with the Immuno-Oncology combination...
Bristol-Myers Squibb Company (NYSE:BMY) will hold an investor event on Monday, June 4, 2018 at 8:30 p.
President Trump's appetite for TV and ratings is legendary and now the administration wants to require drug company TV ads to include the list price of prescription drugs.
Options spreads aren't tradable with some small biotechs, making shares the only way to play.
Bristol-Myers Squibb Company (NYSE:BMY) today announced that data from over 70 Company-sponsored studies and collaborations evaluating its oncology compounds across more than 20 types of cancer will be featured at the American Society of Clinical Oncology...
Jim Cramer weighs in on Consolidated Edison, Clorox, Chesapeake Energy, Adaptimmune Therapeutics, Icahn Enterprises, Bristol-Meyers Squibb and more.
Get ahead of the naysayers, says Jim Cramer. FANG and other tech leaders have gone cold, but they're not dead yet.
Bristol-Myers Squibb Company (NYSE:BMY) will take part in the UBS 2018 Global Healthcare Conference on Tuesday, May 22, 2018, in New York.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.